Ligand Pharmaceuticals Incorporated
LGND NASDAQHealthcare ★★★★★Latest Earnings Above forecast↑
Date
Aug 6, 2026
ET
EPS Est.
2.01
EPS Actual
2.37
Revenue Est.
$61.3M
Revenue Actual
$63.7M
Next Earnings Report
Date
Nov 5, 2026 · Thu
Time
Your time zone matches ET
Pre-market(ET)
Fiscal Period
FY2026 Q3
EPS Est.
2.30
Revenue Est.
$78.1M
Company Overview
Ligand Pharmaceuticals Incorporated (ticker LGND) is listed on NASDAQ with a market cap of about $5.74B. Its next earnings report (FY2026 Q3) is expected on Nov 5, 2026 (ET), Pre-market, with consensus EPS of 2.30. In the last 15 reported quarters, EPS beat consensus estimates 12 times.
Actual EPS TrendRecently15Term · Feb 22, 2023 → Aug 6, 2026
Feb 22, 2023Range: -1.64 ~ 3.09Aug 6, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 6, 2026 | -- | 2.01 | Above forecast↑2.37 | $61.3M | $63.7M |
| May 14, 2026 | -- | 1.84 | 1.63 | $59.1M | $51.7M |
| Feb 26, 2026 | -- | 1.46 | Above forecast↑2.02 | $55.6M | $59.7M |
| Nov 6, 2025 | -- | 1.97 | Above forecast↑3.09 | $58.7M | $115.5M |
| Aug 7, 2025 | -- | 1.42 | 1.60 | $43.9M | $47.6M |
| May 8, 2025 | -- | 1.21 | 1.33 | $38.7M | $45.3M |
| Feb 27, 2025 | -- | 1.37 | Below forecast↓-1.64 | $39M | $42.8M |
| Nov 7, 2024 | -- | 1.35 | Below forecast↓-0.39 | $40.6M | $51.8M |
| Aug 6, 2024 | -- | 1.06 | Above forecast↑1.40 | $33M | $41.5M |
| May 7, 2024 | -- | 0.78 | Above forecast↑1.20 | $27.9M | $31M |
| Feb 27, 2024 | -- | 0.66 | Above forecast↑1.05 | $25.6M | $28.1M |
| Nov 8, 2023 | -- | 0.61 | Above forecast↑1.02 | $27.2M | $32.9M |
| Aug 8, 2023 | -- | 0.64 | Above forecast↑1.42 | $24.7M | $26.4M |
| May 4, 2023 | -- | 0.89 | Above forecast↑2.28 | $33.6M | $44M |
| Feb 22, 2023 | -- | 1.19 | 1.36 | $44.1M | $50.4M |
Original Filings (SEC)
Quarterly10-Q · 2026-08-07 ↗
Earnings Release8-K · 2026-08-06 ↗
Quarterly10-Q · 2026-05-08 ↗
Annual10-K · 2026-02-27 ↗
Earnings Release8-K · 2026-02-26 ↗
Quarterly10-Q · 2025-11-07 ↗
Earnings Release8-K · 2025-11-06 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
